共 13 条
[1]
Clinical and virologic characteristics of chronic active Epstein - Barr virus infection. Kimura H,Hoshino Y,Kanegane H,et al. Blood . 2001
[2]
Epstein - Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. Ohga S,Nomura A,Takada H,et al. The Journal of Infectious Diseases . 2001
[3]
Vidarabine therapy for severe chronic active Epstein - Barr virus infection. Kimura H,Morita M,Tsuge I,et al. Journal of Pediatric Hematology Oncology . 2001
[4]
Blood stem - cell transplantation for chronic active Epstein - Barr virus with lymphopro-liferation. Okamura T,Hatsukawa Y,Aral H,et al. The Lancet . 2000
[5]
Interferon - alpha therapy for chronic active Epstein - Barr virus infection: Potential effect on the development of T - lymphoproliferative disease. Sakai Y,Ohga S,Tonegawa Y,et al. Journal of Pediatric Hematology Oncology . 1998
[6]
Clinical effects of infusing Anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection
[J].
INTERNATIONAL JOURNAL OF HEMATOLOGY,
2003, 78 (01)
:62-68
Hagihara, M
;
Tsuchiya, T
;
Hyodo, O
;
Ueda, Y
;
Tazume, K
;
Masui, A
;
Kanemura, A
;
Yoshiba, F
;
Takashimizu, S
;
Matzusaki, S
;
Kato, S
;
Hotta, T
.
[7]
Successful umbilical cord blood transplantation for severe chronic active Epstein - Barr virus infection after the double failure of hematopoietic stem cell transplan-tation. Ishimura M,Ohga S,Nomura A,et al. American Journal of Hematology . 2005
[8]
Virological aspects of Epstein - Barr virus infections. Yamashita N,Kimura H,Morishima T. Acta Medica Okayama . 2005
[9]
Gamma- interferon for severe chronic active Epstein-Barr virus. Fujisaki T,Nagafuchi S,Okamura T. Annals of Internal Medicine . 1993
[10]
Overview and problematic standpoints of severe chronic active Epstein - Barr virus infection syndrome. Okan M. Critical Reviews in Oncology Hematology . 2002